Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Novanta Inc. (NASDAQ:NOVT). In a filing disclosed on December 15th, the Representative disclosed that they had bought between $1,001 and $15,000 in Novanta stock on November 13th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Sold $1,001 – $15,000 in shares of Spotify Technology (NYSE:SPOT) on 11/26/2025.
- Sold $1,001 – $15,000 in shares of Alphabet (NASDAQ:GOOGL) on 11/26/2025.
- Purchased $1,001 – $15,000 in shares of First Watch Restaurant Group (NASDAQ:FWRG) on 11/26/2025.
- Purchased $1,001 – $15,000 in shares of TKO Group (NYSE:TKO) on 11/26/2025.
- Sold $1,001 – $15,000 in shares of RBC Bearings (NYSE:RBC) on 11/24/2025.
- Sold $1,001 – $15,000 in shares of Stifel Financial (NYSE:SF) on 11/24/2025.
- Purchased $1,001 – $15,000 in shares of Logan Energy (CVE:LGN) on 11/24/2025.
- Sold $1,001 – $15,000 in shares of Primoris Services (NASDAQ:PRIM) on 11/24/2025.
- Purchased $15,001 – $50,000 in shares of LandBridge (NYSE:LB) on 11/21/2025.
- Purchased $50,001 – $100,000 in shares of LandBridge (NYSE:LB) on 11/20/2025.
Novanta Price Performance
NOVT stock traded down $1.82 during trading on Friday, hitting $119.35. 761,303 shares of the stock traded hands, compared to its average volume of 428,396. The company has a 50 day simple moving average of $114.57 and a 200 day simple moving average of $117.59. Novanta Inc. has a one year low of $98.27 and a one year high of $157.11. The stock has a market cap of $4.27 billion, a price-to-earnings ratio of 81.19 and a beta of 1.59. The company has a current ratio of 2.51, a quick ratio of 1.54 and a debt-to-equity ratio of 0.56.
Novanta announced that its board has authorized a stock buyback program on Thursday, September 18th that permits the company to repurchase $200.00 million in outstanding shares. This repurchase authorization permits the technology company to buy up to 4.9% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s board believes its shares are undervalued.
Analyst Ratings Changes
Several equities research analysts have recently commented on the stock. Zacks Research lowered Novanta from a “hold” rating to a “strong sell” rating in a research report on Thursday. Weiss Ratings cut Novanta from a “hold (c-)” rating to a “sell (d+)” rating in a report on Saturday, October 25th. One equities research analyst has rated the stock with a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, Novanta has an average rating of “Sell” and an average price target of $133.00.
Check Out Our Latest Stock Report on NOVT
Hedge Funds Weigh In On Novanta
Institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. lifted its stake in Novanta by 4.6% in the third quarter. Vanguard Group Inc. now owns 4,378,888 shares of the technology company’s stock valued at $438,546,000 after buying an additional 193,366 shares in the last quarter. Conestoga Capital Advisors LLC lifted its position in Novanta by 15.7% in the 2nd quarter. Conestoga Capital Advisors LLC now owns 1,579,626 shares of the technology company’s stock valued at $203,661,000 after acquiring an additional 214,374 shares in the last quarter. Wasatch Advisors LP lifted its position in Novanta by 10.6% in the 2nd quarter. Wasatch Advisors LP now owns 1,100,029 shares of the technology company’s stock valued at $141,827,000 after acquiring an additional 104,985 shares in the last quarter. Geneva Capital Management LLC increased its holdings in Novanta by 5.9% during the 2nd quarter. Geneva Capital Management LLC now owns 988,969 shares of the technology company’s stock worth $127,508,000 after purchasing an additional 54,934 shares in the last quarter. Finally, William Blair Investment Management LLC increased its holdings in Novanta by 5.5% during the 2nd quarter. William Blair Investment Management LLC now owns 979,893 shares of the technology company’s stock worth $126,338,000 after purchasing an additional 51,005 shares in the last quarter. 98.35% of the stock is currently owned by institutional investors and hedge funds.
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
Novanta Company Profile
Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.
Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.
See Also
- Five stocks we like better than Novanta
- What is Forex and How Does it Work?
- 3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&P 500
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- This ETF Caught a Major Tailwind After the Fed’s Rate Cut
- Roth IRA Calculator: Calculate Your Potential Returns
- MarketBeat Week in Review – 12/15 – 12/19
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.
